Message from Chairman
The National Pharmaceutical Pricing Authority (NPPA) was established through a Government of India Resolution on August 29, 1997. NPPA is responsible for the implementation of the National Pharmaceutical Pricing Policy, 2012 and the Drugs (Prices Control) Order (DPCO), 2013. Drug price control, which is prevalent in one form or the other throughout the world, assumes special importance, as it directly impacts the quality of public health. The primary aim of the NPPA is to ensure adequate availability of essential and lifesaving drugs at affordable prices and in doing so, it carefully balances the interests of both the producers and the consumers.
The Pharma Jan Samadhan (PJS), a public grievance portal was launched last year, to facilitate the submission of grievances by the public. PJS has a web-enabled system as well as telephonic helpline. NPPA is committed to redress all the public grievances coming to its notice on priority. An internal guideline in order to streamline the process of recovery from the companies indulging overpricing the medicines and violating various provisions of DPCO, 2013 has been uploaded on our website to ensure transparency and uniformity in dealing with such cases. NPPA has further strengthened its monitoring system for ensuring price compliance and there are about 2700 cases of price violation under examination.
4. With a view to carrying out its functions in a holistic manner, the NPPA maintains close coordination with the concerned Ministries of the Central Government, State Governments, industry associations, consumers and other stakeholder organisations. The price fixation notifications are uploaded on our website along with the calculation sheets which has ensured absolute transparency in the process. NPPA also entertains representation from industry and open to any correction if needed.
5. The Indian drug industry has registered spectacular growth over the last two decades. The annual turnover of domestic pharmaceutical sector stood at Rs. 128,044.29 crores in the year 2013-14 as reported in the Annual Report 2014-15 of the Department of Pharmaceuticals. Export of medicines and Pharmaceutical products touched Rs. 69,023 crores in 2013-14. The Indian Pharmaceutical industry has been a dominant player in manufacturing generic drugs, but of late it has also made significant headway in research and development for developing new and innovative drugs.
Given the inherent advantage of a large and vibrant drug industry in the country and increasing priority attached to public health care by both the Central and State Governments, the NPPA is confident of making its contribution in ensuring sufficient availability of essential and life saving medicines at affordable prices with the cooperation of all concerned, particularly the pharmaceutical industry. NPPA looks forward the cooperation of informed citizens to help us in this mission.
Top of the Page | Home